[EN] ANGIOTENSIN-1-RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DU RÉCEPTEUR DE L'ANGIOTENSINE 1
申请人:FERRING BV
公开号:WO2017207760A1
公开(公告)日:2017-12-07
In one aspect, this disclosure features compounds of formula (I)or a pharmaceutically acceptable salt thereof: AA1-Arg-Val-AA4-AA5-His-Pro-AA8-OH(I), in which AA1, AA4, AA5, and AA8 are defined in the specification. The compounds of formula (I) can be used to treat hypertension(e.g., hypertension induced by pregnancy), preeclampsia,or a renal disease induced bypregnancy.
Angiotensin-1-Receptor Antagonists
申请人:Ferring B.V.
公开号:US20170349629A1
公开(公告)日:2017-12-07
In one aspect, this disclosure features compounds of formula (I) or a pharmaceutically acceptable salt thereof:
AA1-Arg-Val-AA4-AA5-His-Pro-AA8-OH (I),
in which AA1, AA4, AA5, and AA8 are defined in the specification. The compounds of formula (I) can be used to treat hypertension (e.g., hypertension induced by pregnancy), preeclampsia, or a renal disease induced by pregnancy.